Pharmacokinetics, pharmacodynamics and safety of BAY 2433334, a novel activated factor XI inhibitor, in healthy volunteers: A randomized phase 1 multiple‐dose study

por Kubitza, Dagmar, Heckmann, Michael, Distler, Jana, Koechel, Annemone, Schwers, Stephan, Kanefendt, Friederike
Publicado 2022